CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 55 filers reported holding CYTOSORBENTS CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,446 | +52565.8% | 20,450 | 0.0% | 0.04% | -22.8% |
| Q2 2023 | $73 | +12.3% | 20,450 | 0.0% | 0.06% | +16.3% |
| Q1 2023 | $65 | +103.1% | 20,450 | 0.0% | 0.05% | +104.2% |
| Q4 2022 | $32 | -99.9% | 20,450 | -14.4% | 0.02% | -7.7% |
| Q3 2022 | $33,000 | -36.5% | 23,900 | 0.0% | 0.03% | -33.3% |
| Q2 2022 | $52,000 | -31.6% | 23,900 | 0.0% | 0.04% | -13.3% |
| Q1 2022 | $76,000 | -24.0% | 23,900 | 0.0% | 0.04% | -16.7% |
| Q4 2021 | $100,000 | -47.4% | 23,900 | +2.1% | 0.05% | -51.4% |
| Q3 2021 | $190,000 | +9.8% | 23,400 | +2.2% | 0.11% | +9.9% |
| Q2 2021 | $173,000 | -16.4% | 22,900 | -4.2% | 0.10% | -24.1% |
| Q1 2021 | $207,000 | +14.4% | 23,900 | +5.3% | 0.13% | +1.5% |
| Q4 2020 | $181,000 | +13.1% | 22,700 | +13.5% | 0.13% | +1.6% |
| Q3 2020 | $160,000 | – | 20,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 964,141 | $7,829,000 | 1.90% |
| Skylands Capital, LLC | 1,837,541 | $14,921,000 | 1.84% |
| CM Management, LLC | 175,000 | $1,421,000 | 1.06% |
| Soleus Capital Management, L.P. | 800,000 | $6,496,000 | 1.01% |
| Avenir Corp | 1,395,385 | $11,331,000 | 0.95% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 185,000 | $1,502,000 | 0.55% |
| Winning Points Advisors, LLC | 86,200 | $701,000 | 0.51% |
| Granahan Investment Management | 1,154,561 | $9,375,000 | 0.18% |
| SECTORAL ASSET MANAGEMENT INC | 244,660 | $1,987,000 | 0.16% |
| Redmile Group, LLC | 1,044,434 | $8,481,000 | 0.15% |